DK2151241T3 - Stabilt fast præparat, omfattende 4,5-epoxymorphinanderivat - Google Patents
Stabilt fast præparat, omfattende 4,5-epoxymorphinanderivatInfo
- Publication number
- DK2151241T3 DK2151241T3 DK08752145.6T DK08752145T DK2151241T3 DK 2151241 T3 DK2151241 T3 DK 2151241T3 DK 08752145 T DK08752145 T DK 08752145T DK 2151241 T3 DK2151241 T3 DK 2151241T3
- Authority
- DK
- Denmark
- Prior art keywords
- solid preparation
- stable solid
- derivative
- epoxymorphinander
- effective ingredient
- Prior art date
Links
- 239000007787 solid Substances 0.000 title abstract 3
- 239000004615 ingredient Substances 0.000 abstract 3
- QONGLMDHKNFCDX-KBHMWOLSSA-N (4r,4ar,12bs)-1,2,3,4,4a,5,6,7,7a,13-decahydro-4,12-methanobenzofuro[3,2-e]isoquinoline Chemical class O1C2CCC[C@H]3[C@]4([H])NCC[C@]23C2=C1C=CC=C2C4 QONGLMDHKNFCDX-KBHMWOLSSA-N 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 abstract 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 abstract 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 abstract 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 abstract 1
- 235000019345 sodium thiosulphate Nutrition 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
- 150000005846 sugar alcohols Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Epoxy Compounds (AREA)
- Epoxy Resins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2007116721 | 2007-04-26 | ||
| PCT/JP2008/058111 WO2008133330A1 (ja) | 2007-04-26 | 2008-04-25 | ４，５－エポキシモルヒナン誘導体を含有する安定な固形製剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2151241T3 true DK2151241T3 (da) | 2012-04-23 |
Family
ID=39925776
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK08752145.6T DK2151241T3 (da) | 2007-04-26 | 2008-04-25 | Stabilt fast præparat, omfattende 4,5-epoxymorphinanderivat |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8420662B2 (da) |
| EP (1) | EP2151241B1 (da) |
| JP (2) | JP5099127B2 (da) |
| KR (1) | KR101491656B1 (da) |
| CN (1) | CN101686976B (da) |
| AT (1) | ATE550023T1 (da) |
| AU (1) | AU2008244936B2 (da) |
| CA (1) | CA2685131C (da) |
| DK (1) | DK2151241T3 (da) |
| ES (1) | ES2381056T3 (da) |
| MX (1) | MX2009011554A (da) |
| PL (1) | PL2151241T3 (da) |
| PT (1) | PT2151241E (da) |
| WO (1) | WO2008133330A1 (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI455733B (zh) | 2009-03-30 | 2014-10-11 | Toray Industries | 口腔內崩壞性被覆錠劑 |
| EP2630150B1 (en) * | 2010-10-19 | 2017-04-12 | Memorial Sloan-Kettering Cancer Center | 6-amido derivatives of 4,5a-epoxymorphinans for treatment of pain |
| JP2013087170A (ja) * | 2011-10-17 | 2013-05-13 | Nippon Soda Co Ltd | ヒドロキシプロピルセルロース微粒子 |
| WO2013172297A1 (ja) | 2012-05-14 | 2013-11-21 | 塩野義製薬株式会社 | ６，７－不飽和－７－カルバモイルモルヒナン誘導体含有製剤 |
| GB201318394D0 (en) * | 2013-10-17 | 2013-12-04 | Univ Edinburgh | Composition |
| US11046692B2 (en) | 2015-04-30 | 2021-06-29 | Memorial Sloan-Kettering Cancer Center | Mitragynine analogs and uses thereof |
| CN105461727A (zh) * | 2015-12-01 | 2016-04-06 | 吕涛 | 一种纳呋拉啡的精制方法 |
| WO2018021518A1 (ja) | 2016-07-29 | 2018-02-01 | 東レ株式会社 | 光安定性の向上した固形製剤 |
| EP3603643B1 (en) | 2017-03-31 | 2021-09-15 | Toray Industries, Inc. | Tableted medicinal composition comprising nalfurafine |
| US20210015813A1 (en) | 2018-03-08 | 2021-01-21 | Victoria Link Ltd. | Treatment of demyelinating diseases |
| WO2020205735A1 (en) * | 2019-03-29 | 2020-10-08 | Humanwell Pharmaceutical US | Novel morphinans useful for treating medical disorders |
| WO2022265993A1 (en) | 2021-06-14 | 2022-12-22 | Scorpion Therapeutics, Inc. | Urea derivatives which can be used to treat cancer |
| EP4212149A1 (en) * | 2022-01-18 | 2023-07-19 | Rijksuniversiteit Groningen | Oral dosage forms of acid-labile salt and methods and uses related thereto |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8820327D0 (en) | 1988-08-26 | 1988-09-28 | May & Baker Ltd | New compositions of matter |
| KR970011390B1 (ko) | 1992-01-23 | 1997-07-10 | 도레이 가부시키가이샤 | 모르피난 유도체와 약리학적으로 허용되는 이의 산 부가염 및 이를 함유하는 약제학적 조성물 |
| ES2236630T3 (es) * | 1996-11-25 | 2005-07-16 | Toray Industries, Inc. | Agente antipruritico. |
| WO1998035679A1 (de) | 1997-02-14 | 1998-08-20 | Gödecke Aktiengesellschaft | Stabilisierung von naloxonhydrochlorid |
| JP4939680B2 (ja) | 1997-05-27 | 2012-05-30 | 武田薬品工業株式会社 | 固形製剤 |
| TW580397B (en) * | 1997-05-27 | 2004-03-21 | Takeda Chemical Industries Ltd | Solid preparation |
| KR100514963B1 (ko) | 1997-07-11 | 2005-09-15 | 도레이 가부시끼가이샤 | 4,5-에폭시모르피난 유도체를 함유하는 안정한 의약품 조성물 |
| US6524568B2 (en) * | 1998-06-22 | 2003-02-25 | Cytomedix, Inc. | Enriched platelet wound healant |
| DE60110666T2 (de) * | 2000-03-17 | 2006-02-02 | Shin-Etsu Chemical Co., Ltd. | Feste Zubereitung enthaltend niedersubstituierte Hydroxypropylcellulose und Herstellungsverfahren |
| JP3698652B2 (ja) | 2000-03-17 | 2005-09-21 | 信越化学工業株式会社 | 低置換度ヒドロキシプロピルセルロース含有固形製剤及びその製造方法 |
| WO2001076565A1 (fr) | 2000-04-12 | 2001-10-18 | Banyu Pharmaceutical Co., Ltd. | Compositions et preparations se desintegrant dans la cavite buccale |
| JP3595765B2 (ja) * | 2000-09-27 | 2004-12-02 | 信越化学工業株式会社 | 低置換度ヒドロキシプロピルセルロースを含む乾式直打用基剤 |
| WO2002070013A1 (en) | 2001-03-06 | 2002-09-12 | Kyowa Hakko Kogyo Co., Ltd. | Utilization of spray-dried powder containing sugar alcohol |
| ATE510534T1 (de) | 2002-03-14 | 2011-06-15 | Euro Celtique Sa | Naltrexonhydrochlorid-zusammensetzungen |
| US20050208127A1 (en) * | 2002-06-10 | 2005-09-22 | Kazuyoshi Ogasawara | Rapidly disintegrating tablet and process for producing the same |
| HRP20150037T4 (hr) | 2003-04-08 | 2022-09-02 | Progenics Pharmaceuticals, Inc. | Farmaceutske formulacije koje sadrže metilnaltrekson |
-
2008
- 2008-04-25 MX MX2009011554A patent/MX2009011554A/es active IP Right Grant
- 2008-04-25 US US12/597,475 patent/US8420662B2/en active Active
- 2008-04-25 ES ES08752145T patent/ES2381056T3/es active Active
- 2008-04-25 DK DK08752145.6T patent/DK2151241T3/da active
- 2008-04-25 WO PCT/JP2008/058111 patent/WO2008133330A1/ja not_active Ceased
- 2008-04-25 CA CA2685131A patent/CA2685131C/en active Active
- 2008-04-25 KR KR20097021469A patent/KR101491656B1/ko active Active
- 2008-04-25 CN CN2008800136837A patent/CN101686976B/zh active Active
- 2008-04-25 AU AU2008244936A patent/AU2008244936B2/en active Active
- 2008-04-25 JP JP2009511919A patent/JP5099127B2/ja active Active
- 2008-04-25 EP EP08752145A patent/EP2151241B1/en active Active
- 2008-04-25 PL PL08752145T patent/PL2151241T3/pl unknown
- 2008-04-25 AT AT08752145T patent/ATE550023T1/de active
- 2008-04-25 PT PT08752145T patent/PT2151241E/pt unknown
-
2012
- 2012-06-27 JP JP2012144653A patent/JP5578199B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2008244936B2 (en) | 2013-02-21 |
| PL2151241T3 (pl) | 2012-08-31 |
| JP2012180382A (ja) | 2012-09-20 |
| PT2151241E (pt) | 2012-05-07 |
| CN101686976A (zh) | 2010-03-31 |
| EP2151241B1 (en) | 2012-03-21 |
| CA2685131C (en) | 2015-05-19 |
| WO2008133330A1 (ja) | 2008-11-06 |
| CN101686976B (zh) | 2013-04-24 |
| US20100120815A1 (en) | 2010-05-13 |
| AU2008244936A1 (en) | 2008-11-06 |
| ES2381056T3 (es) | 2012-05-22 |
| KR101491656B1 (ko) | 2015-02-09 |
| ATE550023T1 (de) | 2012-04-15 |
| JP5099127B2 (ja) | 2012-12-12 |
| KR20100015582A (ko) | 2010-02-12 |
| EP2151241A4 (en) | 2010-06-02 |
| US8420662B2 (en) | 2013-04-16 |
| MX2009011554A (es) | 2010-01-25 |
| CA2685131A1 (en) | 2008-11-06 |
| JP5578199B2 (ja) | 2014-08-27 |
| EP2151241A1 (en) | 2010-02-10 |
| JPWO2008133330A1 (ja) | 2010-07-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2151241T3 (da) | Stabilt fast præparat, omfattende 4,5-epoxymorphinanderivat | |
| UA109421C2 (uk) | Фармацевтична композиція, яка містить ліганди сигма-рецептора | |
| EA201070698A1 (ru) | Твердые формы 3-(6-(1-(2,2-дифторбензо[d][1,3]-диоксол-5-ил)циклопропанкарбоксамидо)-3-метилпиридин-2-ил)бензойной кислоты | |
| MA32604B1 (fr) | Composes organiques | |
| NO20045072L (no) | Tablett med hoyt medikamentinnhold | |
| TNSN08505A1 (fr) | Compositions pharmaceutiques stabilisees comprenant de la fesoterodine | |
| MA31433B1 (fr) | Inhibiteurs de la p70 s6 kinase | |
| AR072261A1 (es) | Derivados piperazin-pirazolicos, composiciones farmaceuticas que los contienen y usos de los mismos como agentes anticancerigenos. | |
| MY151295A (en) | Pyrimidyl indoline compound | |
| CO6280584A2 (es) | Derivados heterociclicos fungicidas de (tetrazolil-benzilideneamido)-oximetil | |
| UA105229C2 (uk) | Фармацевтичний склад | |
| ECSP088307A (es) | Derivados fungicidas de fenilamidina sustituida con piridiniloxi | |
| UY28797A1 (es) | 5,6-dialquil-7-amino-triazolopirimidinas, procedimientos para su preparación y el uso de las mismas para combatir hongos nocivos, así como productos que las contienen. | |
| ECSP088689A (es) | NOVEDOSAS 11ß-HIDROXIANDROSTA-4-EN-3-ONAS | |
| ATE520406T1 (de) | Kristalline form des ibandronat-natriums | |
| FI3817751T3 (fi) | Vedettömän natriumtiosulfaatin formulaatioita | |
| WO2011006935A3 (en) | Tetrazole derivatives | |
| UA101407C2 (ru) | Стабильная комбинированная фармацевтическая композиция амлодипина и бисопролола фумарат | |
| EA201300715A1 (ru) | Бульонный кубик | |
| MA30554B1 (fr) | Malates et formes polymorphes de l'acide ( 3s,5s)-7-[3-amino-5-methyl-piperidinyl ]-1-cyclopropyl-1,4-dihydro-8- methoxy-4-oxo-3-quinoleine-carboxylique | |
| GT201400027A (es) | Acuosa suspensión concentrada que comprende un ácido sal de dodecilguanidina | |
| EA201000434A1 (ru) | Сокристаллы пириметанила и дитианона | |
| CO6351744A2 (es) | Sales de n-[6-(cis-2,6-dimetil-morfolin-4-il)-piridini-3-il]-2-metil-4´-(trifluoro-metoxi)-[1,1´-bifenil]-3-carboxamida | |
| TN2010000585A1 (en) | Pharmaceutical compositions of rosuvastatin calcium | |
| TR201906042T4 (tr) | Stabilize edilmiş aktif bileşik. |